Logo1
ASHI 38th Annual Meeting & Inspector's Workshop
Mr pencil

How would you like your name to appear on your certificate?



Agreement
By completing this form, you attest that you have attended the activity in its entirety.
Categories:

Gender

ASHI Membership Status :
How often do you try to attend the Annual Meeting?
Current Position:
Do you plan to attend the 39th Annual Meeting?
Registration Process
Housing Process
Abstract Submission
Do you have any suggestions for future meeting locations?

Your primary location of professional activity?

Please rate the following (1 - Satisfactory to 6 - Unsatisfactory):
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Quality of facilities.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with '4,' '5,' or '6,' please explain in detail (e.g. session title, speaker name, situation):
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Objective 3: Discuss the next generation technologies used for partial or whole genomic analysis and to interpret the data these systems generate as they apply to human donor-recipient histocompatibility or detection of biomarkers for rejection.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
Was the mode of education effective for learning?
If you answered 'No' to any of the above questions, please explain:
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered 'Yes' to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this educational program?
What specifically did you learn during this activity that you intend to integrate into your practice?
What questions have arisen in your practice for which you need answers/strategies that you can implement?
What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow-up?
Are you interested in basic, intermediate or advanced level trainings?
What barriers might you have that would interfere with implementation of new information learned from this training?
How could this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?
Additional comments:
Rate the overall quality of the sessions you attended : 1 (Outstanding) to 5 (Poor)
Inspector’s Training Workshop (7.5hrs)
Accreditation & Proficiency Testing Update (1.5hrs)
Keynote Address: Quality, Safety and a Culture of Service Excellence on Pathology (1hr)

Jeffrey L. Myers, MD

Introduction to the Day: Antibodies  and B Cells (.25hrs)

Thalachallour Mohanakumar, PhD

Plenary I: To B or not to B (1.5 hrs)

Regulatory B Cells (Bio Cells) in Health and Disease

Thomas F. Tedder, PhD

BLyS Family Ligands and Receptors

Michael P. Cancro, PhD

Symposium I: Transplantation, From Pillar to Post (1.5)

Tools 

Geoffrey Land, PhD, HCLD

B Cell Tolerance in Organ Transplantation

Ali Naji, MD, PhD

Serology Complements Histology: C4d, C1q, and Morphology in the Diagnosis of Humoral Rejection

Evan A.Farkash, MD

Workshop 1: Case Studies in Solid Organ Transplantation (1.5 hrs)

Workshop 2: The ASHI & AABB Joint Symposium

Carol Pancoska, PhD, D(ABHI), Patricia Kopko, MD, Paul Warner, PhD

Abstract Session 1: HLA Diversity
Abstract Session 2:Evolving Technologies

Dimitri Monos, PhD

Workshop 3: Harmonization of MFI’s (Internal & How the Physicians Use this Information) (1.5 hrs)

Michael Gautreaux, PhD, D(ABHI), John Schmitz, PhD, D(ABMLI, ABHI), Brett Loehmann, CHT, CHS

Introduction to the Day: Clinical Biomarkers (.25)

Peter Nickerson, MD, FRCPC

Plenary II: High Throughput Testing (1.5)

High Dimensional Statistical Analysis of HLA Sequence Feature Associations

Richard Scheuermann, PhD

NCBI Bioinformatic Tools for Integration of MHC and Whole Genome Analyses: Current and Future

Michael Feolo, MS

Symposium II: Applications of Biomarkers in Transplantation

The Discovery, Validation and Implementation of Biomarkers in Transplantation (1.5 hrs)

Daniel Salomon, MD

Genetic Modulators of MHC Gene Expression

Julian Knight, PhD

The ABCs of HLA and HIV

William Hildebrand, PhD, D(ABHI)

Workshop 4: Case Studies in Stem Cell Transplantation (1.5hrs)
Workshop 5: HLA Epitopes in Clinical Histocompatibility Testing

Marcelo Fernández-Viña, PhD, D(ABHI), Anat Tambur, DMD, PhD, D(ABHI), Rene Duquesnoy, PhD

Abstract Session 3: Clinical Metrics for Pre-Transplant Solid Organ Testing
Abstract Session 4: Best of the Rest
International Workshop Update (1.5)

Derek Middleton, DSc, PhD, FRC, PATH

Abstract Session 5: Clinical Relevance of Post-Transplant Antibodies
Abstract Session 6: Immunomodulation
Joint Directors’ & Technologists’ Forum (1.0)
Plenary III: Scientific Award Lectures (1.5 hrs)

Rose Payne Awardee, Paul Terasaki Awardee, Distinguished Scientist Awardee

Symposium III: Awards & Business Meeting (1.5 hrs)
Workshop 6: Crossmatching: Teaching an Old Dog New Tricks (1.5 hrs)

Nancy Higgins, MT, CHS, Malek Kamoun, MD, PhD, Todd Eagar, PhD

Special Abstract Session: Scholar Awards
KPD Workshop (1.5 hrs)

Annette Jackson, PhD, Suzanne McGuire, RN, BSN, CCTC, Jeffery Veale, MD

Plenary IV: State of the Art of HSCT (1.5hrs) 

Transplants from Haplo-Identical Donors

Utilizing Cord Blood Units

Mary Eapen, MD, MS

Utilizing Cord Blood Units
Transplants From HLA-Haploidentical Donors

Ephraim Fuchs, MD

Umbilical Cord Blood Banking & Transplantation

Joanne Kurtzberg, MD

Great Debate: Past, Present and Future of Ambiguities (1.5)

Dennis L. Confer, MD, Marilyn Pollack, PhD, D(ABHI), Marcelo Fernandez-Vina, PhD, D(ABHI)

Mr question